Table 2. Medical conditions reported at diagnosis in patients with a hospital diagnosis of myeloma in 2012.
| Presence | males | females | total | |
|---|---|---|---|---|
| N = 3234 | N = 3048 | N = 6282 | ||
| Renal | 0 | 2693 (83.3%) | 2635 (86.5%) | 5328 (84.8%) |
| 1 | 541 (16.7%) | 413 (13.5%) | 954 (15.2%) | |
| Infection | 0 | 2780 (86.0%) | 2594 (85.1%) | 5374 (85.5%) |
| 1 | 454 (14.0%) | 454 (14.9%) | 908 (14.5%) | |
| Metabolic | 0 | 2730 (84.4%) | 2641 (86.6%) | 5371 (85.5%) |
| 1 | 504 (15.6%) | 407 (13.4%) | 911 (14.5%) | |
| Myeloid toxicity |
0 | 2805 (86.7%) | 2565 (84.2%) | 5370 (85.5%) |
| 1 | 429 (13.3%) | 483 (15.8%) | 912 (14.5%) | |
| Vascular | 0 | 3147 (97.3%) | 2967 (97.3%) | 6114 (97.3%) |
| 1 | 87 (2.7%) | 81 (2.7%) | 168 (2.7%) | |
| Peripheral neuropathy | 0 | 3206 (99.1%) | 3031 (99.4%) | 6237 (99.3%) |
| 1 | 28 (0.9%) | 17 (0.6%) | 45 (0.7%) | |
| Bone lesions | 0 | 3213 (99.4%) | 3023 (99.2%) | 6236 (99.3%) |
| 1 | 21 (0.6%) | 25 (0.8%) | 46 (0.7%) |